1. Name Of The Medicinal Product
Anbesol Adult Strength Gel
2. Qualitative And Quantitative Composition
Lidocaine Hydrochloride 2.0% w/w
Chlorocresol 0.1% w/w
Cetylpyridinium Chloride 0.02% w/w
3. Pharmaceutical Form
Gel for oral administration.
4. Clinical Particulars
4.1 Therapeutic Indications
For the temporary relief of pain caused by recurrent mouth ulcers, denture irritation.
4.2 Posology And Method Of Administration
Adults, the elderly and children over 12 years: apply a small amount to the affected area with a clean fingertip. One application should be sufficient. Use up to four times a day.
Not for use in children under 12 years.
4.3 Contraindications
In patients with a known history of hypersensitivity or allergic type reactions to any of the constituents of the product.
4.4 Special Warnings And Precautions For Use
If symptoms persist for more than 7 days or recur frequently, consult your doctor, pharmacist or dentist.
Keep all medicines out of the reach and sight of children.
4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction
None known.
4.6 Pregnancy And Lactation
No special precautions required.
4.7 Effects On Ability To Drive And Use Machines
None known.
4.8 Undesirable Effects
There have been reports of non-specific ulceration following oral cetylpyridinium chloride therapy.
4.9 Overdose
Overdose is extremely unlikely considering the small size of the tube used for sale.
5. Pharmacological Properties
5.1 Pharmacodynamic Properties
Lidocaine hydrochloride: Lidocaine is a local anaesthetic of the amide type which acts by reversible inhibition of nerve impulse generation and transmission.
Chlorocresol: Chlorocresol has a disinfectant action.
Cetylpyridinium chloride: Cetylpyridinium chloride has a disinfectant action.
5.2 Pharmacokinetic Properties
Lidocaine hydrochloride: Lidocaine is readily absorbed from mucous membranes and through damaged skin. Lidocaine undergoes first-pass metabolism in the liver and about 90% is dealkylated to form monoethylglycinexylidide and glycinexylidide. Further metabolism occurs and the metabolites are excreted in the urine with less than 10% as unchanged lidocaine.
Chlorocresol: There is no significant absorption of chlorocresol through the skin or mucous membranes.
Cetylpyridinium chloride: There is no significant absorption of cetylpyridinium chloride through the skin or mucous membranes.
5.3 Preclinical Safety Data
The active ingredients in Anbesol Adult Strength Gel have a well established safety record.
6. Pharmaceutical Particulars
6.1 List Of Excipients
Alcohol 96%
Glycerin
Clove Oil
Sodium Saccharin
Hydroxypropyl Cellulose
Ponceau 4R (E124)
Purified Water
6.2 Incompatibilities
None known.
6.3 Shelf Life
36 months unopened.
6.4 Special Precautions For Storage
Do not store above 25°C
6.5 Nature And Contents Of Container
Membrane sealed lacquered aluminium tubes fitted with plastic caps containing 10g gel.
6.6 Special Precautions For Disposal And Other Handling
None.
7. Marketing Authorisation Holder
Alliance Pharmaceuticals Limited
Avonbridge House
Bath Road
Chippenham
Wiltshire
SN15 2BB
UK
8. Marketing Authorisation Number(S)
PL 16853/0127
9. Date Of First Authorisation/Renewal Of The Authorisation
14 December 1998
10. Date Of Revision Of The Text
29th July 2011
No comments:
Post a Comment